Shin Poong Pharm.Co.,Ltd. manufactures and sells pharmaceutical products in South Korea. The company offers cephalosporin antibiotics; penicillin antibiotics; and finished products. It also provides active pharmaceutical ingredients; Pyramax, an anti-malarial drug; drugs for treating hypercholesterolemia, knee osteoarthritis and shoulder periarthritis, and surgical adhesion barrier; and over the counter products. The company also exports its products to approximately 50 countries. Shin Poong Pharm.Co.,Ltd. was founded in 1962 and is headquartered in Seoul, South Korea.
P/S ratio for Shin Poong Pharm.Co.,Ltd. (019170.KS)
P/S ratio as of 2023: 3.53
According to Shin Poong Pharm.Co.,Ltd.'s latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 3.53. At the end of 2022 the company had a P/S ratio of 5.02.
P/S ratio history for Shin Poong Pharm.Co.,Ltd. from 2007 to 2023
P/S ratio at the end of each year
| Year | P/S ratio |
|---|---|
| 2023 | 3.53 |
| 2022 | 5.02 |
| 2021 | 8.65 |
| 2020 | 31.56 |
| 2019 | 1.91 |
| 2018 | 1.67 |
| 2017 | 2.13 |
| 2016 | 1.49 |
| 2015 | 0.76 |
| 2014 | 0.80 |
| 2013 | 0.82 |
| 2012 | 0.91 |
| 2011 | 0.72 |
| 2010 | 0.48 |
| 2009 | 0.43 |
| 2008 | 0.35 |
| 2007 | 0.55 |